Celldex to Participate in Upcoming November Investor Conferences
Rhea-AI Summary
Celldex Therapeutics (NASDAQ:CLDX) announced participation in several upcoming investor conferences in November 2022. Management will engage in fireside chats at the Guggenheim 4th Annual Immunology and Neurology Conference on November 14, at 2:10 PM ET, followed by the Jefferies London Healthcare Conference on November 16 at 4:45 AM ET. The final conference is the Evercore ISI 5th Annual HealthCONx Conference on November 30 at 4:45 PM ET. Webcasts will be accessible on the Celldex website, with replays available for 30 days.
Positive
- None.
Negative
- None.
News Market Reaction – CLDX
On the day this news was published, CLDX declined 0.26%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
HAMPTON, N.J., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that management will participate in fireside chats at the following investor conferences in November:
- Guggenheim 4th Annual Immunology and Neurology Conference on Monday, November 14, 2022 at 2:10 p.m. ET
- Jefferies London Healthcare Conference on Wednesday, November 16, 2022 at 4:45 a.m. ET / 9:45 a.m. GMT
- Evercore ISI 5th Annual HealthCONx Conference on Wednesday, November 30, 2022 at 4:45 p.m. ET
Webcasts of the presentations will be available on the "Events & Presentations" of the "Investors & Media" section of the Celldex website. Replays will be available for 30 days following the events.
About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com.
Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com
Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com
FAQ
What investor conferences is Celldex participating in November 2022?
What is the schedule for Celldex's investor conferences in November 2022?
Will Celldex's conference presentations be available online?
What is Celldex's stock symbol?
